RISK ASSESSMENT OF ADVANCED THERAPY MEDICINAL PRODUCTS [PDF]
Безопасность и риск фармакотерапии, 2018 Advanced therapy medicinal products (ATMP) represent a heterogeneous group of medicinal products, combined with the need for special regulation of their circulation.
R. N. Alyautdin +5 more
doaj +2 more sources
Production Aspects of Advanced Therapy Medicinal Products
, 2022 Poster presented at the 2022 Conference of the European Association of Health Law (EAHL) in Ghent.
Veran, Julie +7 more
core +6 more sources
Measures to minimize cross-contamination risks in Advanced Therapy Medicinal Product manufacturing
ScienceOpen Research, 2014 Current European regulations define in vitro expanded cells for clinical purposes as substantially manipulated and include them in the class of Advanced Therapy Medicinal Products to be manufactured in compliance with current Good Manufacturing Practice.
Livia Roseti +2 more
doaj +2 more sources
Advanced Therapy Medicinal Products: What's in a Name? [PDF]
Journal of Pharmaceutical Sciences, 2020 In this commentary I briefly discuss the term advanced therapy medicinal products (ATMPs). The last two words, medicinal products, correctly indicate that we are dealing with medicines. However, oftentimes ATMPs and products within the ATMP family are erroneously called therapies, which may raise confusion, as illustrated with some examples, and may ...
Jiskoot, W.
openaire +5 more sources
Innovation and competition in advanced therapy medicinal products [PDF]
EMBO Molecular Medicine, 2019 Advanced therapy medicinal products (ATMPs), including gene therapy, cell therapy and tissue engineering products, represent a paradigm shift in health care, but they are expensive. E. Seoane‐Vazquez, V. Shukla and R. Rodriguez‐Monguio discuss ATMPs prospects for the generics market.[Image: see text]
Enrique Seoane‐Vazquez +2 more
openaire +5 more sources
Cell therapy medicinal product regulatory framework in Europe and its application for MSC based therapy development [PDF]
Frontiers in Immunology, 2012 Advanced therapy medicinal products (ATMPs), including cell therapy products, form a new class of medicines in the European Union. Since ATMPs are at the forefront of scientific innovation in medicine, specific regulatory framework has been developed for
Janis eAncans
doaj +2 more sources
Therapeutic Proteins and Advanced Therapy Medicinal Products [PDF]
, 2023 This chapter is divided in two parts: Therapeutic proteins and Advanced Therapy Medicinal Products (ATMPs). Therapeutic Proteins. Therapeutic proteins are large molecules that are different from low molecular weight medicines. They consist of amino acid chains, sometimes decorated with polysaccharides (glycoproteins) that fold in space in secondary and
Eppink, Michel +6 more
openaire +5 more sources
Advanced Therapy Medicinal Products for Eye Diseases: Goals and Challenges
, 2021 Producción ...
Diebold Luque, María Yolanda +50 more
openaire +3 more sources
Ocular Drug, Gene and Cellular Delivery Systems and Advanced Therapy Medicinal Products [PDF]
Türk Oftalmoloji Dergisi, 2018 Due to recent advances in science and technology, when the products used in therapy are examined, ophthalmology has a priority in terms of research and development, preclinical and clinical studies of innovative drugs, medical devices and drug-medical ...
Türkan Eldem, Bora Eldem
doaj +2 more sources
Regulatory Framework for Advanced Therapy Medicinal Products in Europe and United States [PDF]
Frontiers in Pharmacology, 2019 Advanced therapy medicinal products (ATMPs) are a fast-growing field of innovative therapies. The European Union (EU) and the United States (US) are fostering their development.
Carolina Iglesias-Lopez +5 more
doaj +2 more sources